EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson’s Disease

Diego Ploper iD, Agustín O Pernicone, Rodrigo H Tomas-Grau, Verónica E Manzano, Sergio B Socías, María Del Milagro Teran, Valentina Budeguer Isa, Bernardo Sosa-Padilla, Florencia González-Lizárraga, César L Avila, María Laura Guayán, Silvina Chaves und 4 weitere

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Diego Ploper und 15 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA) (CONICET), Universidad Nacional de Tucumán (UNT), Ministerio de Salud Púb…. Hauptthemen laut MEDLINE: Neuroprotective Agents, Parkinson Disease, Drug Design, Dopamine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Consejo Nacional de Investigaciones Cient?ficas y T?cnicas, Agencia Nacional de Promoci?n Cient?fica y Tecnol?gica, Universidad Nacional de Tucum?n.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating prevalence of Parkinson's disease (PD) underscores the need for innovative therapeutic interventions since current palliative measures, including the standard l-Dopa formulations, face challenges of tolerance and side effects while failing to address the underlying neurodegenerative processes. Here, we introduce DAD9, a novel conjugate molecule that aims to combine symptomatic relief with disease-modifying strategies for PD. Crafted through knowledge-guided chemistry, the molecule combines a nonantibiotic doxycycline derivative with dopamine, preserving neuroprotective attributes while maintaining dopaminergic agonism. This compound exhibited no off-target effects on PD-relevant cell functions and sustained antioxidant and anti-inflammatory properties of the tetracycline precursor. Furthermore, it effectively interfered with the formation and seeding of toxic α-synuclein aggregates without producing detrimental oxidative species. In addition, DAD9 was able to activate dopamine receptors, and docking simulations shed light onto the molecular details of this interaction. These findings position DAD9 as a potential neuroprotective dopaminergic agonist, promising advancements in PD therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsParkinson DiseaseDrug DesignDopamineHumansalpha-SynucleinDoxycyclineDopamine AgonistsMolecular Docking SimulationAnimals

Stichwörter der Autor:innen

DAD9Parkinson’s diseaseα-synuclein

Substanzen

Neuroprotective AgentsDopaminealpha-SynucleinDoxycyclineDopamine Agonists

Autor:innen und Institutionen

  • Instituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA) (CONICET), Universidad Nacional de Tucumán (UNT), Ministerio de Salud Pública de Tucumán - SIPROSA, Pasaje Dorrego 1080, 4000 San Miguel de Tuc…
  • Facultad de Ciencias Exactas y Naturales, Departamento de Química Orgánica, Universidad de Buenos Aires, Pabellón 2, C1428EHA Buenos Aires, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro de Investigación en Hidratos de Carbono (CIHIDECAR), Ciudad Universitaria, C1428EHA Buenos Aires, Argentina.
  • Instituto de Química del Noroeste Argentino (INQUINOA) (CONICET), Universidad Nacional de Tucumán (UNT), Ayacucho 471, 4000 San Miguel de Tucumán, Tucumán, Argentina.
  • Instituto de Química Física, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, San Lorenzo 456, 4000 San Miguel de Tucumán, Tucumán, Argentina.

ORCID-Profile: Diego Ploper, Oscar Varela

Förderung

  • Consejo Nacional de Investigaciones Cient?ficas y T?cnicas
  • Agencia Nacional de Promoci?n Cient?fica y Tecnol?gica
  • Universidad Nacional de Tucum?n
  • SKYBIO LLC

Zitieren

APA

Ploper, D., Pernicone, A. O., Tomas-Grau, R. H., Manzano, V. E., Socías, S. B., Teran, M. D. M., Budeguer Isa, V., Sosa-Padilla, B., González-Lizárraga, F., Avila, C. L., Guayán, M. L., Chaves, S., Cruz, H., Vera Pingitore, E., Varela, O., & Chehín, R. (2024). Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00169

Vancouver

Ploper D, Pernicone AO, Tomas-Grau RH, Manzano VE, Socías SB, Teran MDM, et al. Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson’s Disease. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00169

BibTeX
@article{Ploper2024,
  author = {Ploper, Diego and Pernicone, Agustín O and Tomas-Grau, Rodrigo H and Manzano, Verónica E and Socías, Sergio B and Teran, María Del Milagro and Budeguer Isa, Valentina and Sosa-Padilla, Bernardo and González-Lizárraga, Florencia and Avila, César L and Guayán, María Laura and Chaves, Silvina and Cruz, Hernán and Vera Pingitore, Esteban and Varela, Oscar and Chehín, Rosana},
  title = {Design, Synthesis, and Evaluation of a Novel Conjugate Molecule with Dopaminergic and Neuroprotective Activities for Parkinson’s Disease},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00169}
}
Kostenlos starten →